Respirology

Papers
(The H4-Index of Respirology is 29. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Language concordance in healthcare: Beyond just talk124
Epilogue to contemporary perspectives in COPD: New Horizons104
Decline in respiratory and cardiac admissions during the COVID‐19 pandemic: What is the role of common respiratory virus infections?86
P4‐13: Assessment of the impact of atmospheric air microsuspensions on the respiratory function of patients with chronic obstructive pulmonary disease84
O5‐5: Current smoking by socioeconomic status in a representative Japanese population66
P6‐17: Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis (MTB) identification in patients with pulmonary tuberculosis65
P5‐109: A fatal case of multiple mycotic pulmonary artery aneurysms due to Aspergillus terreus in a post COVID‐19 patient58
O18‐3: Analysis of nocturnal desaturation waveform by using algorithm in the patients with idiopathic pulmonary fibrosis49
P7‐65: Correlation between body mass index (BMI) and chronic obstructive pulmonary disease (COPD)47
P11‐14: Blood gas analysis and alveolar‐arterial gradient as predictor of mortality confirmed COVID‐19 patients outcome in Tertiary Referral Hospital46
P8‐177: Chest wall Ewing's sarcoma – A diagnostic and therapeutic adventure46
P5‐43: A case of hyperpyrexia of hypothalamic origin associated with severe COVID‐19 pneumonia in pregnancy43
P10‐12: Risk factors for poor sleep quality and excessive daytime sleepiness in late pregnancy: A preliminary analysis of a cross‐sectional survey42
P1‐66: Metastatic pulmonary calcification mimicking miliary pulmonary tuberculosis: A case report40
P1‐15: Chest X‐ray improvement in COVID‐19 moderate symptoms with remdesvir and favipiravir: A comparative study40
P8‐26: Study of the number of courses required for the first response to immune checkpoint inhibitor (+chemo) therapy for lung cancer39
O5‐4: The effects of smoking cessation therapy on pulmonary function and predictive factor of the FEV1 increase38
O20‐1: Spinal cord infarction after bronchial artery embolization using coils for hemoptysis: A single‐center retrospective analysis of 3046 procedures37
O18‐5: Sleep apnea and academic performance: A study on medical students using the Berlin questionnaire37
P16‐93: Preliminary analysis of serum risk factors during an acute exacerbation of chronic fibrosing interstitial pneumonia: A multi‐institutional prospective study35
O3‐6: The Pulmonary Endothelium Plays a Critical Role in the Fibrotic Response to Lung Injury through S1PR1 and ROCK Mediated Cytoskeletal Rearrangements34
P6‐28: Clinical case of using intravenous forms of anti‐tuberculosis drugs to improve the treatment efficiency of tuberculosis in patients with malabsorption syndrome (MS)32
P12‐21: The recommended image features of peripheral lung parenchymal targets for diagnosis by CT‐guided needle biopsy32
P1‐88: Persistent bilateral unprovoked pulmonary embolism ‐ A case of chronic thromboembolic pulmonary hypertension in a young lady with seronegative antiphospholipid syndrome32
P6‐36: Components system of nitric oxide as markers of pulmonary multi‐drug resistant tuberculosis process activity32
P9‐27: Clinical feature and effectiveness of benralizumab therapy for severe asthma31
P8‐83: Giant pleuro parenchymal metastases from a rare primary tumor31
P5‐55: What kind of disease has developed in a teenager against the background of a new coronavirus infection? Is it Kawasaki's or Reye's syndrome?30
P11‐8: Surviving covid: A case report on the first covid survivor after extracorporeal membrane oxygenation (ECMO) in the Philippines29
Improving support of informal carers of respiratory patients29
P9‐85: The reaction of the pituitary‐adrenal system to cold bronchoprovocation in asthma patients with subclinical hypothyroidism29
0.12662792205811